• Chest · Mar 2014

    Integration of mesenchymal stromal cells delivered in a fibrin sealant during the initial phases of lung parenchyma healing in an animal model.

    • Marcelo Fernando Jiménez López, M Teresa Gómez-Hernández, Dolores Ludeña, Begoña García-Cenador, and Consuelo Cañizo.
    • Chest. 2014 Mar 1;145(3 Suppl):53A.

    Session TitleThoracic Surgery PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: In this study, we have assessed the ability of mesenchymal stromal cells MSCs to differentiate and to contribute in lung repair and how these cells are able to integrate in the initial healing process after a lung parenchyma injury in an animal model.MethodsMSCs were obtained from a human bone marrow aspirate and were grown in vitro. They were applied directly to lung parenchyma injuries induced in sterile conditions in eleven white rats using a fibrin polymer system (Tisseel®). Lung specimens were analyzed after 2, 4, 7 and 14 days of the application of the MSCs according to the different healing phases. The analysis consisted of hematoxylin-eosin staining and immunohistochemical study using antibodies binding specifically to human mitochondria.ResultsMSCs identified by anti-human mitochondrial antibodies were found in all phases of the lung parenchyma scarring. After two days, these cells showed morphological characteristics of macrophages. Four days after, some of these cells had turned into fibroblasts. During the differentiation phase, coinciding with the seventh day, MSCs-derived fibroblasts were predominant. Fourteen days after the injury, only a small number of cells binding human mitochondrial antibodies were detected and they were well integrated in the repaired areas.ConclusionsThese findings indicate that human bone marrow-derived MSCs have the ability to integrate in the damaged parenchyma expressing different morphological features along the main healing phases and they can be effectively delivered using a fibrin sealant system.Clinical ImplicationsRecent studies have suggested that mesenchymal stromal cells (MSCs) are promising candidates for cell-based tissue engineering, to repair or replace damaged tissues.DisclosureThe following authors have nothing to disclose: M. Teresa Gómez-Hernández, Maria Rodríguez, Marcelo Fernando Jiménez López, Dolores Ludeña, Begoña García-Cenador, Consuelo CañizoNo Product/Research Disclosure Information.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.